The activation of STAT3 by receptor tyrosine kinases, such as EGFR and MET, cytokine receptors, such as IL-6 receptor, and non-receptor kinases, such as Src, regulates survival pathways in certain NSCLC cells (Figure 1) [59]. The gene discussed is STAT3; the disease is non-small cell lung carcinoma.